Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Maria Irno Consalvo"'
Autor:
Isabella Faraoni, Maria Irno Consalvo, Francesca Aloisio, Emiliano Fabiani, Manuela Giansanti, Francesca Di Cristino, Giulia Falconi, Lucio Tentori, Ambra Di Veroli, Paola Curzi, Luca Maurillo, Pasquale Niscola, Francesco Lo-Coco, Grazia Graziani, Maria Teresa Voso
Publikováno v:
Cancers, Vol 11, Iss 9, p 1373 (2019)
Myelodysplastic syndromes (MDS) are highly heterogeneous myeloid diseases, characterized by frequent genetic/chromosomal aberrations. Olaparib is a potent, orally bioavailable poly(ADP-ribose) polymerase 1 (PARP1) inhibitor with acceptable toxicity p
Externí odkaz:
https://doaj.org/article/bafd0129937942e08b93db55cbff3d60
Autor:
Luca Maurillo, Francesco Buccisano, Alessandra Spagnoli, Giovanni Del Poeta, Paola Panetta, Benedetta Neri, Maria Ilaria Del Principe, Carla Mazzone, Maria Irno Consalvo, Anna Tamburini, Licia Ottaviani, Daniela Fraboni, Chiara Sarlo, Paolo De Fabritiis, Sergio Amadori, Adriano Venditti
Publikováno v:
Haematologica, Vol 92, Iss 5 (2007)
Background and Objectives To date, bone marrow (BM) is the most common source of cells to use in order to assess minimal residual disease (MRD) in acute myeloid leukemia (AML). In the present study, we investigated whether peripheral blood (PB) could
Externí odkaz:
https://doaj.org/article/07773c52fa3545059e2c955e5beafcd8
Autor:
Francesco Lo-Coco, Luca Battistini, Adriano Venditti, Sergio Amadori, Giorgio Bernardi, Giovanna Borsellino, Maria Irno Consalvo, Nélida I. Noguera, Mariadomenica Divona, Luca Maurillo, Francesca Gargano, Marco De Bardi, Francesco Buccisano, Michela Cittadini, Serena Lavorgna, Gisella Guerrera, Tiziana Ottone, Daniela F. Angelini
Supplementary Figure 2. MPFC detection limit.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a501f94ed7adacfe42efa3195886b9b
https://doi.org/10.1158/1078-0432.22457649
https://doi.org/10.1158/1078-0432.22457649
Autor:
Francesco Lo-Coco, Luca Battistini, Adriano Venditti, Sergio Amadori, Giorgio Bernardi, Giovanna Borsellino, Maria Irno Consalvo, Nélida I. Noguera, Mariadomenica Divona, Luca Maurillo, Francesca Gargano, Marco De Bardi, Francesco Buccisano, Michela Cittadini, Serena Lavorgna, Gisella Guerrera, Tiziana Ottone, Daniela F. Angelini
Supplementary Table 3. MPFC analysis of total AML bone marrow sample according to FLT3 mutational status.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::325f51e07305caa35f3acdc45a5a1317
https://doi.org/10.1158/1078-0432.22457637.v1
https://doi.org/10.1158/1078-0432.22457637.v1
Autor:
Francesco Lo-Coco, Luca Battistini, Adriano Venditti, Sergio Amadori, Giorgio Bernardi, Giovanna Borsellino, Maria Irno Consalvo, Nélida I. Noguera, Mariadomenica Divona, Luca Maurillo, Francesca Gargano, Marco De Bardi, Francesco Buccisano, Michela Cittadini, Serena Lavorgna, Gisella Guerrera, Tiziana Ottone, Daniela F. Angelini
Supplementary Table 4. MPFC analysis of AML bone marrow sample according to FLT3 or NPM1 mutational status.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::927723115f43fd4210a2c2a5da33ae8a
https://doi.org/10.1158/1078-0432.22457634.v1
https://doi.org/10.1158/1078-0432.22457634.v1
Autor:
Francesco Lo-Coco, Luca Battistini, Adriano Venditti, Sergio Amadori, Giorgio Bernardi, Giovanna Borsellino, Maria Irno Consalvo, Nélida I. Noguera, Mariadomenica Divona, Luca Maurillo, Francesca Gargano, Marco De Bardi, Francesco Buccisano, Michela Cittadini, Serena Lavorgna, Gisella Guerrera, Tiziana Ottone, Daniela F. Angelini
Supplementary Table 1. anti-human antibodies used.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7438e80dc5f8b69cef45da2879c241e2
https://doi.org/10.1158/1078-0432.22457643
https://doi.org/10.1158/1078-0432.22457643
Autor:
Francesco Lo-Coco, Luca Battistini, Adriano Venditti, Sergio Amadori, Giorgio Bernardi, Giovanna Borsellino, Maria Irno Consalvo, Nélida I. Noguera, Mariadomenica Divona, Luca Maurillo, Francesca Gargano, Marco De Bardi, Francesco Buccisano, Michela Cittadini, Serena Lavorgna, Gisella Guerrera, Tiziana Ottone, Daniela F. Angelini
Supplementary Table 5. Longitudinal analysis of FLT3-ITDs using patient-specific RQPCR in four AML patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e801639cdcd55ef7213db33043fb960
https://doi.org/10.1158/1078-0432.22457631.v1
https://doi.org/10.1158/1078-0432.22457631.v1
Autor:
Francesco Lo-Coco, Luca Battistini, Adriano Venditti, Sergio Amadori, Giorgio Bernardi, Giovanna Borsellino, Maria Irno Consalvo, Nélida I. Noguera, Mariadomenica Divona, Luca Maurillo, Francesca Gargano, Marco De Bardi, Francesco Buccisano, Michela Cittadini, Serena Lavorgna, Gisella Guerrera, Tiziana Ottone, Daniela F. Angelini
Supplementary Figure 3. MPFC and molecular analysis of UPN 241 bone marrow samples at diagnosis, during follow-up and at relapse.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4002e51cc0187ad7acfebf283d236f83
https://doi.org/10.1158/1078-0432.22457646
https://doi.org/10.1158/1078-0432.22457646
Autor:
Francesco Lo-Coco, Luca Battistini, Adriano Venditti, Sergio Amadori, Giorgio Bernardi, Giovanna Borsellino, Maria Irno Consalvo, Nélida I. Noguera, Mariadomenica Divona, Luca Maurillo, Francesca Gargano, Marco De Bardi, Francesco Buccisano, Michela Cittadini, Serena Lavorgna, Gisella Guerrera, Tiziana Ottone, Daniela F. Angelini
Purpose: We evaluated leukemia-associated immunophenotypes (LAIP) and their correlation with fms-like tyrosine kinase 3 (FLT3) and nucleophosmin (NPM1) gene mutational status in order to contribute a better identification of patients at highest risk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::157ccd1f37f9bfaeedd966e81287d253
https://doi.org/10.1158/1078-0432.c.6523635
https://doi.org/10.1158/1078-0432.c.6523635
Autor:
Giuseppe Sconocchia, Giulia Lanzilli, Valeriana Cesarini, Domenico A Silvestris, Katayoun Rezvani, Roberto Arriga, Sara Caratelli, Ken Chen, Jinzhuang Dou, Carlo Cenciarelli, Gabriele Toietta, Silvia Baldari, Tommaso Sconocchia, Francesca De Paolis, Anna Aureli, Giandomenica Iezzi, Maria Irno Consalvo, Francesco Buccisano, Maria I del Principe, Luca Maurillo, Adriano Venditti, Alessio Ottaviani, Giulio C Spagnoli
The FcγRII (CD32) ligands are IgFc fragments and pentraxins. The existence of additional ligands is unknown. We engineered T cells with human chimeric receptors resulting from the fusion between CD32 extracellular portion and transmembrane CD8α lin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7d94e7643368932ed25648cf607c3be
https://hdl.handle.net/2108/307175
https://hdl.handle.net/2108/307175